| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Departments of Microbiology [H. C. I., M. J. T] and Pathology [J. W. K.] and Specialized Cancer Research Center, The Pennsylvania State University College of Medicine, Hershey, Pennsylvania 17033
Simian virus 40 (SV40)-transformed F344 rat hepatocytes were transplanted into newborn and normal and irradiated adult syngeneic F344 hosts. Three independently isolated SV40-transformed hepatocyte cell lines were inoculated s.c. into newborn syngeneic animals. One cell line, SV40hpl, produced tumors in two of 12 animals. Fixed tissue sections indicated that the tumors were relatively undifferentiated but had some epithelial cells and contained a peripheral mononuclear leukocyte infiltrate. Serum from a tumor-bearing animal tested by immunoprecipitation demonstrated antibodies to SV40 large- T- but not to small-t-antigen. A portion of one of the tumors was used to prepare the tumor cell line SV40hpl-1, which was 100% positive by immunofluorescence for SV40 nuclear T- antigen. In adult F344 rats subjected previously to whole-body irradiation, inoculation of SV40hpl-1 cells produced tumors in 83% of the animals. Continued passage of the tumor cell line in irradiated rats produced a tumor in one animal which paralyzed its host. The cell line derived from this tumor (SV40hpl-1-T1-2) was tumorigenic in nonirradiated adult hosts. The tumor cell lines were morphologically similar to each other but different from the SV40hpl-transformed cell line; the tumor cells contained less cytoplasm and grew to high densities in strings or multilayered foci without covering the dish surface. All tumor cells retained SV40 antigen expression, and at least one complete copy of the virus genome was retained through two passages in animals.
We concluded that SV40 transformation of rat hepatocytes can produce a tumorigenic cell line. We have shown previously that SV40-transformed hepatocytes retain the ability to express proteins characteristic of adult differentiated liver. Development of this model system will enable us to examine expression of these proteins not only in transformed cells with tumorigenic potential but also in tumor tissue and transplantable tumor cell lines.
1 Supported in part by National Cancer Institute Grants CA 27503, CA 18450, and by the Jake Gittlen Memorial Golf Tournament.
2 Recipient of Grant CA 23931 from the National Cancer Institute. To whom requests for reprints should be addressed.
3 Recipient of Grant CA 24694 from the National Cancer Institute. Scholar of the Leukemia Society of America, Inc.
4 Recipient of Grant CA 22869 from the National Cancer Institute.
Received 10/20/80. Accepted 2/17/81.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |